Published in Curr Opin Immunol on August 01, 1991
Interleukin-10 modulates susceptibility in experimental cerebral malaria. Immunology (1997) 1.73
Thalidomide inhibits the replication of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1993) 1.61
Immunological markers indicating the effectiveness of pharmacological treatment in human hydatid disease. Clin Exp Immunol (1995) 1.49
Gamma interferon modifies CD4+ subset expression in murine candidiasis. Infect Immun (1992) 1.19
Effects of cytokines, complement, and antibody on the neutrophil respiratory burst and phagocytic response to Plasmodium falciparum merozoites. Infect Immun (1992) 1.18
In vitro production of cytokines by peripheral blood mononuclear cells from hydatid patients. Clin Exp Immunol (1995) 1.18
Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factor. Am J Pathol (1998) 1.07
CD4 T cells and major histocompatibility complex class II expression influence worm expulsion and increased intestinal muscle contraction during Trichinella spiralis infection. Infect Immun (1999) 1.02
Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science (1991) 8.85
Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science (1999) 8.63
Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science (1991) 6.12
An antimicrobial activity of cytolytic T cells mediated by granulysin. Science (1998) 5.02
Induction of direct antimicrobial activity through mammalian toll-like receptors. Science (2001) 4.46
The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol (1999) 4.10
Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis. J Immunol (1990) 3.85
Differential effects of cytolytic T cell subsets on intracellular infection. Science (1997) 3.39
Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science (1997) 3.23
Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest (1993) 3.15
Cytokine production at the site of disease in human tuberculosis. Infect Immun (1993) 3.04
Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J Immunol (1992) 3.03
Cytokine patterns of immunologically mediated tissue damage. J Immunol (1992) 2.72
T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J Clin Invest (1994) 2.51
Nonpeptide ligands for human gamma delta T cells. Proc Natl Acad Sci U S A (1994) 2.33
Compartmentalization of a CD4+ T lymphocyte subpopulation in tuberculous pleuritis. J Immunol (1989) 2.27
Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2. J Immunol (2001) 2.24
In situ demonstration of T lymphocyte subsets in granulomatous inflammation: leprosy, rhinoscleroma and sarcoidosis. Clin Exp Immunol (1983) 2.21
CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family. J Immunol (1996) 2.13
The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity (1997) 2.07
Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules. J Exp Med (1999) 2.06
The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol (1993) 2.04
Characterization of T cell antigens associated with the cell wall protein-peptidoglycan complex of Mycobacterium tuberculosis. J Immunol (1989) 2.01
T lymphocyte subsets in the skin lesions of patients with leprosy. J Am Acad Dermatol (1983) 2.01
Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. J Immunol (1993) 2.00
Interleukin 12 at the site of disease in tuberculosis. J Clin Invest (1994) 1.98
CD1-restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell pool. J Immunol (1999) 1.96
Analysis of fluorescence decay curves by means of the Laplace transformation. Biophys J (1975) 1.96
A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages. J Immunol (2000) 1.90
Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction. Clin Exp Immunol (1993) 1.88
Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect Immun (1996) 1.85
Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization. J Exp Med (1989) 1.82
Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest (1996) 1.79
Gamma delta T lymphocytes in human tuberculosis. J Infect Dis (1992) 1.78
Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10. J Immunol (2000) 1.77
In situ identification of cells in human leprosy granulomas with monoclonal antibodies to interleukin 2 and its receptor. J Immunol (1984) 1.74
Mouse CD1 is mainly expressed on hemopoietic-derived cells. J Immunol (1997) 1.73
Patterns of cytokine production by mycobacterium-reactive human T-cell clones. Infect Immun (1993) 1.72
IL-12 regulates T helper type 1 cytokine responses in human infectious disease. J Immunol (1994) 1.65
Molecular recognition of lipid antigens by T cell receptors. J Exp Med (1999) 1.65
Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis. Proc Natl Acad Sci U S A (2000) 1.65
Molecular interaction of CD1b with lipoglycan antigens. Immunity (1998) 1.60
In situ characterization of T lymphocyte subsets in the reactional states of leprosy. Clin Exp Immunol (1983) 1.60
The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens. Immunity (1998) 1.59
Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions. Nature (1986) 1.56
Tumor necrosis factor production in patients with leprosy. Infect Immun (1992) 1.55
Suppressor T lymphocytes from lepromatous leprosy skin lesions. J Immunol (1986) 1.55
Isolation and characterization of the highly immunogenic cell wall-associated protein of Mycobacterium leprae. J Immunol (1989) 1.54
Immunoreactivity of a 10-kDa antigen of Mycobacterium tuberculosis. J Immunol (1992) 1.52
A predominance of the T cell receptor V gamma 2/V delta 2 subset in human mycobacteria-responsive T cells suggests germline gene encoded recognition. J Immunol (1991) 1.52
Stigma variations: observations on suppressor T cells and leprosy. Annu Rev Immunol (1992) 1.51
T cell mediated immunity to Mycobacterium tuberculosis. Curr Opin Microbiol (1999) 1.46
IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response. J Immunol (1995) 1.42
T-cell release of granulysin contributes to host defense in leprosy. Nat Med (2001) 1.40
Dermatology-Important Advances in Clinical Medicine: Kaposi's Sarcoma: Current Trends. West J Med (1983) 1.40
Granulysin, a T cell product, kills bacteria by altering membrane permeability. J Immunol (2000) 1.39
Evidence for clonal selection of gamma/delta T cells in response to a human pathogen. J Exp Med (1991) 1.38
Down-regulation of CD1 on antigen-presenting cells by infection with Mycobacterium tuberculosis. J Immunol (1998) 1.35
IL-15, an immunomodulator of T cell responses in intracellular infection. J Immunol (1997) 1.34
Immunologic responsiveness in American cutaneous leishmaniasis lesions. J Immunol (1990) 1.33
CD1 expression by dendritic cells in human leprosy lesions: correlation with effective host immunity. J Immunol (1999) 1.32
Single-cell cytokine analysis of gamma delta T cell responses to nonpeptide mycobacterial antigens. J Immunol (1997) 1.30
Toll-like receptors: molecular mechanisms of the mammalian immune response. Immunology (2000) 1.27
Cytokine patterns at the site of mycobacterial infection. Immunobiology (1994) 1.26
IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection. J Immunol (1999) 1.24
Local expression of antiinflammatory cytokines in cancer. J Clin Invest (1993) 1.21
Antigen specificity of gamma delta T lymphocytes. FASEB J (1991) 1.16
The role of Toll-like receptors in host defense against microbial infection. Curr Opin Immunol (2001) 1.15
Immunological significance of Mycobacterium leprae cell walls. Proc Natl Acad Sci U S A (1988) 1.15
Predictors of short-term prognosis in patients with pulmonary tuberculosis. J Infect Dis (1988) 1.15
Determinants of T cell reactivity to the Mycobacterium leprae GroES homologue. J Immunol (1997) 1.14
In situ characterization of the cellular immune response in American cutaneous leishmaniasis. Clin Exp Immunol (1985) 1.13
Evidence for human CD4+ T cells in the CD1-restricted repertoire: derivation of mycobacteria-reactive T cells from leprosy lesions. J Immunol (2000) 1.12
The T cell receptors of human gamma delta T cells reactive to Mycobacterium tuberculosis are encoded by specific V genes but diverse V-J junctions. J Immunol (1991) 1.11
IL-15 enhances the response of human gamma delta T cells to nonpeptide [correction of nonpetide] microbial antigens. J Immunol (1998) 1.10
Evidence for a superantigen in human tuberculosis. Immunity (1994) 1.10
In situ and in vitro characterization of the cellular immune response in erythema nodosum leprosum. J Immunol (1986) 1.09
Microanatomic clonality of gamma delta T cells in human leishmaniasis lesions. J Immunol (1992) 1.08
Expression of adhesion molecules in leprosy lesions. Infect Immun (1991) 1.05
Expression of interleukin-12 in synovial tissue from patients with rheumatoid arthritis. Arthritis Rheum (1998) 1.05
Immunology. A Toll for DNA vaccines. Nature (2000) 1.05
Granulysin: a lethal weapon of cytolytic T cells. Immunol Today (1999) 1.03
Signaling lymphocytic activation molecule is expressed on CD40 ligand-activated dendritic cells and directly augments production of inflammatory cytokines. J Immunol (2001) 1.03
Potentiation of the macrophage 25-hydroxyvitamin D-1-hydroxylation reaction by human tuberculous pleural effusion fluid. J Clin Endocrinol Metab (1989) 1.02
Transpleural gradient of 1,25-dihydroxyvitamin D in tuberculous pleuritis. J Clin Invest (1989) 1.01
The role of gamma delta T lymphocytes in infection. Curr Opin Immunol (1991) 1.01
Interferon-gamma differentially regulates interleukin-12 and interleukin-10 production in leprosy. J Clin Invest (1997) 1.01
Selection of T lymphocytes bearing limited T-cell receptor beta chains in the response to a human pathogen. Proc Natl Acad Sci U S A (1993) 1.01
T-lymphocyte subsets in lymph nodes from homosexual men. JAMA (1983) 1.01
CTL-mediated killing of intracellular Mycobacterium tuberculosis is independent of target cell nuclear apoptosis. J Immunol (2000) 1.00
Altered distribution of B and T lymphocytes in lymph-nodes from homosexual men with Kaposi's sarcoma. Lancet (1983) 0.98
CD1 and the expanding universe of T cell antigens. J Immunol (1995) 0.98
A role for IL-12 receptor expression and signal transduction in host defense in leprosy. J Immunol (2001) 0.98
CD1-restricted T cells and resistance to polysaccharide-encapsulated bacteria. Immunol Today (1998) 0.95
Tissue and blood T-lymphocyte subpopulations in erythema nodosum leprosum. Arch Dermatol (1985) 0.95
T-cell recognition of non-peptide antigens. Curr Opin Immunol (1996) 0.94
Immunopathology of leprosy skin lesions. Semin Dermatol (1991) 0.94
A role for CD40-CD40 ligand interactions in the generation of type 1 cytokine responses in human leprosy. J Immunol (2000) 0.93
CD1 presentation of microbial nonpeptide antigens to T cells. J Clin Invest (1997) 0.93
Epidermal keratinocyte Ia expression, Langerhans cell hyperplasia and lymphocytic infiltration in skin lesions of leprosy. Clin Exp Immunol (1986) 0.93